UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status
Unique ID issued by UMIN UMIN000002023
Receipt No. R000002469
Scientific Title The change for blood level of antibacterial agent in blood purification therapy for sepsis.
Date of disclosure of the study information 2009/06/01
Last modified on 2009/06/01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title The change for blood level of antibacterial agent in blood purification therapy for sepsis.
Acronym The change for blood level of antibacterial agent in blood purification therapy for sepsis.
Scientific Title The change for blood level of antibacterial agent in blood purification therapy for sepsis.
Scientific Title:Acronym The change for blood level of antibacterial agent in blood purification therapy for sepsis.
Region
Japan

Condition
Condition sepsis
Classification by specialty
Intensive care medicine
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The evaluation for dose of antibacterial agent in blood purification therapy for sepsis.
Basic objectives2 Pharmacokinetics
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The evaluation for blood level of antibacterial agent in blood purification therapy for sepsis.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria 1)sepsis
2)acute or chronic renal failure
3)blood purification therapy
4)antibacterial therapy
patient fulfilles 1), 2), 3)and 4).
Key exclusion criteria none.
Target sample size 10

Research contact person
Name of lead principal investigator
1st name
Middle name
Last name Yoshitaka Hara
Organization Kainan Hospital
Division name Department of Emergency, Critical Care Medicine and Anesthesiology
Zip code
Address 396 Minami honden, Maegasu-cho, Yatomi-city, Aichi, Japan
TEL 0567-65-2511
Email

Public contact
Name of contact person
1st name
Middle name
Last name Yoshitaka Hara
Organization Kainan Hospital
Division name Department of Emergency, Critical Care Medicine and Anesthesiology
Zip code
Address 396 Minami honden, Maegasu-cho, Yatomi-city, Aichi, Japan
TEL 0567-65-2511
Homepage URL
Email harahara19801201@yahoo.co.jp

Sponsor
Institute Kainan Hospital
Institute
Department

Funding Source
Organization Kainan Hospital
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization
Address
Tel
Email

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2009 Year 06 Month 01 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status
Date of protocol fixation
2009 Year 06 Month 01 Day
Date of IRB
Anticipated trial start date
2009 Year 06 Month 01 Day
Last follow-up date
2012 Year 05 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information First, we will evaluate about meropenem or linezolid.

Management information
Registered date
2009 Year 06 Month 01 Day
Last modified on
2009 Year 06 Month 01 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002469

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.